The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of FS.COM Limited 深圳市飛速創新技術股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited l ...

Sanmina (NasdaqGS:SANM) 2025 Conference December 02, 2025 02:50 PM ET Company ParticipantsJon Faust - EVP and CFOConference Call ParticipantsAna Gasco - AnalystAna GascoWelcome, everyone, to Bank of America's 2025 Leverage Finance Conference. I'm Ana Gasco, and from the credit research side, I cover technology and telecom, and I'm thrilled to have Sanmina with us today, and we have Jon Faust, the company's Executive Vice President and CFO, so Jon, thank you so much for being with us.Jon FaustYeah, thank you ...

Core Insights - China's economy is transitioning to a new focus on artificial intelligence, robotics, and innovative pharmaceuticals, marking a significant shift in its industrial landscape [1][2][4] Industry Dynamics - Technology companies now represent over 25% of China's A-share market, with their market capitalization surpassing that of banking, non-bank financial, and real estate sectors, indicating a paradigm shift towards tech-driven growth [3] - The robotics sector is highlighted as a key area, with companies like Inovance Technology exceeding a market cap of 200 billion yuan and Sanxie Motor experiencing a 785% surge on its debut trading day [6] - In the AI sector, firms such as Cambricon and Foxconn Industrial Internet have market caps over 100 billion yuan, with record-high order books and profit margins in H1 2024 [7] - Innovative pharmaceuticals are also gaining traction, with Hengrui Pharmaceuticals nearing a 500 billion yuan market cap, while other companies like WuXi AppTec and Hansoh Pharma exceed 100 billion yuan [8] Global Positioning - China's robotics sector is moving from a "catch-up" phase to a leadership role globally, characterized by a complete industrial chain and the largest market, although it still relies on imports for high-end servo motors [9] - AI is in a catch-up phase overall but shows leadership in specific applications like computer vision and speech recognition, facing challenges in core chip production where NVIDIA holds 80% of the market [9] - The innovative pharmaceuticals sector is transitioning from following to catching up, with increased international recognition for R&D capabilities despite challenges in target discovery [9] Strategic Recommendations - To address existing bottlenecks, it is suggested to unlock cross-sector data, expedite approvals for life-saving technologies, and enhance computing infrastructure and talent training [10] - Implementing regulatory sandboxes is recommended to foster innovation while avoiding restrictive policies [10] - Engaging in global tech standard-setting is crucial for ensuring China's influence in the international arena [10] Investment Outlook - The shift to the new "new trio" reflects China's industrial upgrading logic, with leading enterprises and supportive policies indicating a strong investment climate [11] - For international investors, this represents a strategic opportunity for tech-driven expansion in China, leveraging its market size and robust industrial ecosystems [12]

Core Insights - POET Technologies Inc. has appointed Dr. Ghazi M. Chaoui as Senior Vice President of Global Manufacturing and Digital Transformation to enhance its manufacturing capabilities in Malaysia [1][2] - The company has established POET Technologies Sdn. Bhd. as a wholly owned subsidiary in Malaysia, with full production capacity expected to be operational this quarter [3][4] - POET focuses on high-speed optical modules and engines for AI systems and hyperscale data centers, utilizing its patented Optical Interposer technology for efficient integration of electronic and photonic devices [4] Company Developments - Dr. Chaoui brings nearly 40 years of experience in manufacturing and supply chain management, having held key roles in various technology companies [2][3] - The company aims to meet the high demand for 800G and 1.6T transceivers required by hyperscalers and AI cluster operators [2] - POET's manufacturing operations in Penang, Malaysia, are set to enhance the company's ability to deliver optical engines to customers efficiently [3][4] Technology and Market Position - POET's Optical Interposer platform allows for lower-cost, lower-power, and smaller-sized optical products that are scalable to high production volumes [4] - The company is positioned to address bandwidth and latency challenges in AI systems through its novel light source products for chip-to-chip communication [4] - POET's technology also addresses integration challenges in 5G networks and various applications such as autonomous vehicle sensing [4]